MedX Health Corp MDX.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -34.03% | 30.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -34.03% | 30.51% | |||
| Cost of Revenue | -36.03% | -60.31% | |||
| Gross Profit | -29.96% | 140.32% | |||
| SG&A Expenses | 23.12% | -13.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.09% | -20.89% | |||
| Operating Income | -31.78% | 26.51% | |||
| Income Before Tax | -29.82% | 40.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -29.82% | 40.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -29.82% | 40.21% | |||
| EBIT | -31.78% | 26.51% | |||
| EBITDA | -30.15% | 26.52% | |||
| EPS Basic | -29.63% | 42.55% | |||
| Normalized Basic EPS | -29.41% | 34.62% | |||
| EPS Diluted | -29.63% | 42.55% | |||
| Normalized Diluted EPS | -29.41% | 34.62% | |||
| Average Basic Shares Outstanding | 0.00% | 2.43% | |||
| Average Diluted Shares Outstanding | 0.00% | 2.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||